QBAL Tablet

ក្រុមហ៊ុនផលិតឱសថ:

 

BOSCH PHARMACEUTICALS (Pvt)Ltd., Pakistan

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • ការប្រុងប្រយ័ត្នជាពិសេស
  • សកម្មភាពឱសថ
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    Peripheral Neuropathies.

    Megaloblastic anemia caused by vitamin B12 deficiency.

    Dosage and Administration

    The usual adult dosage for oral use is 3 tablets daily in 3 divided doses.

    The dosage may be adjusted depending on the patient’s age and symptoms.

  • ហាមប្រើ

    Hypersensitivity to mecobalamin or other Vitamin B12 containing products.

  • ផលរំខាន

    In case of tablets, symptoms such as anorexia, nausea or diarrhoea may infrequently occur.

  • ការប្រុងប្រយ័ត្នជាពិសេស

    Mecobalamin should not be used for more than 1 month unless it is effective.

    Prolonged use of larger doses of mecobalamin is not recommended for patients whose occupation requires handling mercury or its compounds. Since this drug decomposes on exposure to light, it should be used immediately after the package is opened.

  • សកម្មភាពឱសថ

    1. Mecobalamin is a kind of endogenous coenzyme B12

    Mecobalamin plays an important role in transmethylation as a coenzyme of methionine synthetase in the synthesis of methionine from homocysteine.

    2. Mecobalamin is well transported to nerve cell organelles, and promotes nucleic acid and protein synthesis.

    Mecobalamin is better transported to nerve cell organelles than cyanocobalamin in rats. It has been shown in experiments with cells from the brain origin and spinal nerve cells in mice to be involved in the synthesis of thymidine from deoxyuridine, promotion of deposited folic acid utilization and metabolism of nucleic acid. Also Mecobalamin promotes nucleic acid and protein synthesis in rats more than cobamamide does.

    3. Mecobalamin promotes axonal transport and axonal regeneration.

    Mecobalamin normalizes axonal skeletal proteins transport in sciatic cells from rat models with streptozotocin induced diabetes mellitus. It exhibits neuropathologically and electrophysiologically inhibitory effects on nerve degeneration in neuropathies induced by drugs, such as adriamycin, acrylamide and vincristine (in rats and rabbits), models of axonal degeneration in mice and neuropathies in rats with spontaneous diabetes mellitus.

    4. Mecobalamin promotes myelination (phospholipid synthesis).

    Mecobalamin promotes the synthesis of lecithin, the main constituent of medullary sheath lipids, and increases myelination of neurons in rat tissue culture more than cobamamide does.

    5. Mecobalamin restores delayed synaptic transmission and diminished neurotransmitters to normal.

    Mecobalamin restores end-plate potential induction early by increasing nerve fiber excitability in the crushed sciatic nerve in rats. In addition, Mecobalamin normalized diminished brain tissue levels of acetylcholine in rats fed a choline-deficient diet.

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp